Mometasone + formoterol

Trade Name:

Zenhale

Manufacturer/Distributor:

Merck

1-800-567-2594

Classification:

Corticosteroid + long-acting beta2- agonist

ATC Class:

R03AB07 Mometasone; R03AC13 Formoterol

Status:

active

Notice of Compliance (yyyy/mm/dd):

2011/01/11

Date Marketed in Canada (yyyy/mm/dd):

2011/02/01

Presentation:

Inhaler: 50 mcg mometasone + 5 mcg formoterol. DIN: 02361744

Inhaler: 100 mcg mometasone + 5 mcg formoterol. DIN: 02361752

Inhaler: 200 mcg mometasone + 5 mcg formoterol. DIN: 02361760

Comments:

Inhaler used twice daily for maintenance of asthma in adults and children 12 years of age and older with reversible obstructive airway disease, whose asthma cannot be adequately controlled with asthma controller medications.

Keywords:

formoterol

Keywords:

mometasone

Keywords:

asthma

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Chlorpropamide	Apo-chlorpropamide	Antidiabetic agent	2017/02/01
Cilazapril	Inhibace	ACE inhibitor
Cladribine	Mavenclad	Immunosuppressant	2017/11/30
Clindamycin + tretinoin	Biacna	Antimicrobial + keratolytic	2010/04
Clofedanol	Ulone	Antitussive
Colesevelam	Lodalis	Bile acid sequestrant	2012/02/06
Crisaborole	Eucrisa	PDE-4 inhibitor	2018/08/29
Crizotinib	Xalkori	ALK Tyrosine Kinase Inhibitor
Cyclosporine	Restasis	Topical immunomodulator with anti-inflammatory effects	2010/10
Daclatasvir	Daklinza	Antiviral agent	2015/09/08
Dacomitinib	Vizimpro	Tyrosine kinase inhibitor	2019/04/22
Dapgliflozin	Forxiga	Sodium-glucose contransporter 2 (SGLT2) inhibitor	2016/02/10
Dapgliflozin + metformin	Xigduo	Sodium-glucose contransporter 2 (SGLT2) inhibitor plus metformin	2016/02/08
Dapsone	Aczone	Anti-acne therapy	2011/10/21
Daratumumab	Darzalex SC	Antineoplastic agent, monoclonal antibody	2020/08/12
Darolutamide	Nubeqa	Anti-androgen	2020/03/24
Darunavir	Prezista	Antiviral agent	2006
Degarelix	Firmagon	Antineoplastic agent	2009/11
Denosumab	Prolia	RANK Ligand inhibitor	2010/08/10
Denosumab	Xgeva	Bone resorption inhibitor	2011/10/05
Desogestrel + ethinyl estradiol	Apri	Oral contraceptive	2009-03-18
Desonide	Verdeso	Corticosteroid	2011/04/20
Desvenlafaxine	Pristiq	Antidepressant	2009/03/02
Dexamethasone	Ozurdex	Corticosteroid	2012/01/19
Dexlansoprazole	Dexilant	Proton pump inhibitor	2010/07/26
Dexmedetomidine	Precedex	Alpha-2 adrenergic agonist	2010/02/24
Diclofenac potassium	Cambia	NSAID	2012/10
Dienogest	Visanne	Progestin	2011/12/
Difluprednate	Durezol	Topical corticosteroid	2014/03/12
Digoxin	Apo-digoxin; pms-Digoxin; Lanoxin
Digoxin Immune Fab (Ovine)	Digifab	Antidote	2011/12/09
Digoxin Immune Fab (Ovine)	Digibind	Antidote
Dimethyl fumarate	Tecfidera	Misc. central nervous system agent	2013/04
Dimeticone	Nyda	Pediculocide	2012/01/17
Dolasetron mesylate injection	Anzemet	Antiemetic	2011/05/10
Doravirine	Pifeltro	NNRTI	2018/11/15